Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Trial in Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen

NCT00003418 is registered in ClinicalTrials.gov with International Collaborative Cancer Group as lead sponsor.

NCT NCT00003418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Trial in Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen
Lead sponsor
International Collaborative Cancer Group
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 1998
Completion date
Not reported
Enrollment
4,400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer